| 摘要 |
<p>Humanized anti-CD20 antibodies are provided that may be used for the treatment of diseases and conditions associated with CD20-expressing cells. Also provided are nucleic acids encoding such antibodies, methods of making such antibodies, and compositions comprising such antibodies.</p> |
